These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28965496)

  • 1. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
    Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter Evaluation of the Modified Carbapenem Inactivation Method and the Carba NP for Detection of Carbapenemase-Producing Pseudomonas aeruginosa and Acinetobacter baumannii.
    Simner PJ; Johnson JK; Brasso WB; Anderson K; Lonsway DR; Pierce VM; Bobenchik AM; Lockett ZC; Charnot-Katsikas A; Westblade LF; Yoo BB; Jenkins SG; Limbago BM; Das S; Roe-Carpenter DE
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29118172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doripenem vs meropenem against Pseudomonas and Acinetobacter.
    Goyal K; Gautam V; Ray P
    Indian J Med Microbiol; 2012; 30(3):350-1. PubMed ID: 22885206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
    Mushtaq S; Vickers A; Woodford N; Livermore DM
    J Antimicrob Chemother; 2017 Jun; 72(6):1688-1695. PubMed ID: 28333319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09.
    Davies TA; Marie Queenan A; Morrow BJ; Shang W; Amsler K; He W; Lynch AS; Pillar C; Flamm RK
    J Antimicrob Chemother; 2011 Oct; 66(10):2298-307. PubMed ID: 21775338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of carbapenemase-producing Pseudomonas aeruginosa and Acinetobacter baumannii in livestock animals in Lebanon.
    Al Bayssari C; Dabboussi F; Hamze M; Rolain JM
    J Antimicrob Chemother; 2015 Mar; 70(3):950-1. PubMed ID: 25406297
    [No Abstract]   [Full Text] [Related]  

  • 8. Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Dias VC; Resende JA; Bastos AN; De Andrade Bastos LQ; De Andrade Bastos VQ; Bastos RV; Diniz CG; Da Silva VL
    Microb Drug Resist; 2017 Oct; 23(7):852-863. PubMed ID: 28437232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Carbapenem-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Clinical Isolates Collected from Some Libyan Hospitals.
    Mathlouthi N; Areig Z; Al Bayssari C; Bakour S; Ali El Salabi A; Ben Gwierif S; Zorgani AA; Ben Slama K; Chouchani C; Rolain JM
    Microb Drug Resist; 2015 Jun; 21(3):335-41. PubMed ID: 25587875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct detection of carbapenemase-associated proteins of Acinetobacter baumannii using nanodiamonds coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
    Chang KC; Chung CY; Yeh CH; Hsu KH; Chin YC; Huang SS; Liu BR; Chen HA; Hu A; Soo PC; Peng WP
    J Microbiol Methods; 2018 Apr; 147():36-42. PubMed ID: 29499232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of the 29-kilodalton outer membrane protein in the presence of OXA-51-like enzymes in Acinetobacter baumannii is associated with decreased imipenem susceptibility.
    Jeong HW; Cheong HJ; Kim WJ; Kim MJ; Song KJ; Song JW; Kim HS; Roh KH
    Microb Drug Resist; 2009 Sep; 15(3):151-8. PubMed ID: 19728771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences between meropenem and imipenem disk to detect carbapenemase in gram-negative bacilli using simplified carbapenem inactivation method.
    Wan D; Jing X; Zhou H; Min X; Zhang X; Wu T; Liu R; Zeng J
    J Infect Chemother; 2020 Jun; 26(6):636-639. PubMed ID: 32173284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    Zhang X; Gu B; Mei Y; Wen Y; Xia W
    J Antibiot (Tokyo); 2015 Feb; 68(2):115-20. PubMed ID: 25182483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem inactivation: a very affordable and highly specific method for phenotypic detection of carbapenemase-producing Pseudomonas aeruginosa isolates compared with other methods.
    Akhi MT; Khalili Y; Ghotaslou R; Kafil HS; Yousefi S; Nagili B; Goli HR
    J Chemother; 2017 Jun; 29(3):144-149. PubMed ID: 27443547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Detection of VIM-4-Producing Pseudomonas aeruginosa and OXA-48-Producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria.
    Mellouk FZ; Bakour S; Meradji S; Al-Bayssari C; Bentakouk MC; Zouyed F; Djahoudi A; Boutefnouchet N; Rolain JM
    Microb Drug Resist; 2017 Apr; 23(3):335-344. PubMed ID: 27314660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
    Marti S; Sánchez-Céspedes J; Alba V; Vila J
    Int J Antimicrob Agents; 2009 Feb; 33(2):181-2. PubMed ID: 18977642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and Molecular Characterization of New Delhi Metallo-Beta-Lactamases in Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii from India.
    Rahman M; Prasad KN; Gupta S; Singh S; Singh A; Pathak A; Gupta KK; Ahmad S; Gonzalez-Zorn B
    Microb Drug Resist; 2018; 24(6):792-798. PubMed ID: 29058515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
    Nastro M; Ayora M; García S; Vay C; Famiglietti Á; Rodriguez CH
    J Chemother; 2017 Jun; 29(3):150-153. PubMed ID: 27347714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition of blaOXA-58-like to blaOXA-23-like in Acinetobacter baumannii Clinical Isolates in Southern China: An 8-Year Study.
    Wu W; He Y; Lu J; Lu Y; Wu J; Liu Y
    PLoS One; 2015; 10(9):e0137174. PubMed ID: 26340666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.